Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Dynamic, helminth-induced immune modulation influences the outcome of acute and chronic hepatitis B virus infection.
J. Infect. Dis. 221, 1448-1461 (2020)
Background. Chronic hepatitis B develops more frequently in countries with high prevalence of helminth infections. The crosstalk between these 2 major liver-residing pathogens, Schistosoma mansoni and hepatitis B virus (HBV), is barely understood.Methods. We used state-of-the-art models for both acute and chronic HBV infection to study the pathogen-crosstalk during the different immune phases of schistosome infection.Results. Although liver pathology caused by schistosome infection was not affected by either acute or chronic HBV infection, S mansoni infection influenced HBV infection outcomes in a phase-dependent manner. Interferon (IFN)-gamma secreting, HBV- and schistosome-specific CD8 T cells acted in synergy to reduce HBV-induced pathology during the T(H)1 phase and chronic phase of schistosomiasis. Consequently, HBV was completely rescued in IFN-gamma-deficient or in T(H)2 phase coinfected mice demonstrating the key role of this cytokine. It is interesting to note that secondary helminth infection on the basis of persistent (chronic) HBV infection increased HBV-specific T-cell frequency and resulted in suppression of virus replication but failed to fully restore T-cell function and eliminate HBV.Conclusions. Thus, schistosome-induced IFN-gamma had a prominent antiviral effect that outcompeted immunosuppressive effects of T(H)2 cytokines, whereas HBV coinfection did not alter schistosome pathogenicity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.022
1.307
5
5
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Coinfection ; Hepatitis B ; Immunomodulation ; Liver ; Schistosoma Mansoni; Regulatory T-cells; C Virus; Schistosomiasis; Liver; Mice; Replication; Coinfection; Prevalence; Responses
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
2019
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0022-1899
e-ISSN
1537-6613
Zeitschrift
Journal of Infectious Diseases, The
Quellenangaben
Band: 221,
Heft: 9,
Seiten: 1448-1461
Verlag
Oxford University Press
Verlagsort
Journals Dept, 2001 Evans Rd, Cary, Nc 27513 Usa
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Virology (VIRO)
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-502700-003
G-502700-001
G-502700-001
WOS ID
WOS:000536512000010
Scopus ID
85083881306
PubMed ID
31875228
Erfassungsdatum
2020-01-10